Form 4: Aardvark Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Susan E Graf, a Director of Aardvark Therapeutics, Inc., received 44,964 shares of common stock on August 14, 2026.
Summary
- Grant/award: acquired 44,964 Stock Option (right to buy) on August 14, 2026; holds 44,964 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Susan E Graf — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Grant/award | Stock Option (right to buy) | 44,964 | — | — | 44,964 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Grant/award (44,964 shares) |
Keywords
insider transaction, Form 4, AARD, Aardvark Therapeutics, Inc., neutral, Susan E Graf
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.